
Godavari BiorefineriesQ3 FY25
Godavari Biorefineries Q3 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹202.97P/E: 36.0Market Cap: ₹1.0K Cr
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- Ethanol business expected to grow significantly in FY26 and FY27 due to investments in grain-based distillation and government ethanol blending program participation.
- Bio-based chemical segment to expand with debottlenecking and new biobutanol technology licensing, targeting commissioning in Q2 FY27.
- Sugar segment anticipated to remain largely static in revenue contribution.
- Focus on multi-feedstock ethanol production (sugarcane and grain/corn) to mitigate climate and policy risks.
- Expansion in specialty bio-based chemicals such as 1,3-butylene glycol and ethyl vinyl ether expected due to strong demand in fragrances, skincare, coatings, and adhesives.
- Revenue in biochemical segment poised to grow from increased volume and new product launches, with potential Rs. 250 crore revenue from biobutanol facility at full capacity by second year.
- Export growth through co-creation of bio-based chemical solutions for Indian and global markets.
See what Godavari Biorefineries management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- The company has already reduced debt by Rs. 240 crores using IPO proceeds.
- There will be new borrowing under the interest subvention scheme to fund the grain-based ethanol facility (dual-feed corn/grain-based distillation plant).
- Targeted borrowing for this project is around Rs. 119 crores at approximately 5.4% interest.
- The company is actively investing in debottlenecking chemical capacities and constructing a biobutanol plant, indicating ongoing capital expenditure plans.
- No specific mention of upcoming equity fundraising beyond the IPO.
- Overall, future funding will be a combination of new borrowings for ethanol programs, normal principal repayments, and working capital needs.
See what Godavari Biorefineries management said on order book — free account, 30 seconds.
Capex plans
Yes- Investment in a new dual-feed 200 KL/day corn/grain-based ethanol facility targeted for commissioning in Q4 FY26 (H2 FY26) to enhance ethanol production capacity and mitigate climate and policy risk.
- Licensing of technology from Catalyxx Incorporated for biobutanol and higher alcohol production with a first phase plant capacity of 15,000 tons/year; commissioning planned in Q2 FY27.
- Debottlenecking of bio-based specialty chemical capacities, including recent expansion of 1,3 butylene glycol capacity from 120 to 200 tons/month, with further debottlenecking planned in coming quarters.
- Continued transition and investment focus on ethanol blending program and bio-based chemicals as core growth strategies.
- Capital investments expected to improve operational efficiencies and support sustainable growth.
- Total gross block as of now is Rs. 1,245 crores, with further capitalization planned especially in ethanol and bio-based chemicals segments.
Track Godavari Biorefineries — get its next earnings analysis in your feed
How does Godavari Biorefineries rank vs peers in ?
Pro featureThisGodavari Biorefineries
Rev 2Mar 3